Literature DB >> 17204575

Parenchymal tethering, airway wall stiffness, and the dynamics of bronchoconstriction.

Jason H T Bates1, Anne-Marie Lauzon.   

Abstract

We do not yet have a good quantitative understanding of how the force-velocity properties of airway smooth muscle interact with the opposing loads of parenchymal tethering and airway wall stiffness to produce the dynamics of bronchoconstriction. We therefore developed a two-dimensional computational model of a dynamically narrowing airway embedded in uniformly elastic lung parenchyma and compared the predictions of the model to published measurements of airway resistance made in rats and rabbits during the development of bronchoconstriction following a bolus injection of methacholine. The model accurately reproduced the experimental time-courses of airway resistance as a function of both lung inflation pressure and tidal volume. The model also showed that the stiffness of the airway wall is similar in rats and rabbits, and significantly greater than that of the lung parenchyma. Our results indicate that the main features of the dynamical nature of bronchoconstriction in vivo can be understood in terms of the classic Hill force-velocity relationship operating against elastic loads provided by the surrounding lung parenchyma and an airway wall that is stiffer than the parenchyma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17204575     DOI: 10.1152/japplphysiol.00980.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  37 in total

1.  Continuum vs. spring network models of airway-parenchymal interdependence.

Authors:  Baoshun Ma; Jason H T Bates
Journal:  J Appl Physiol (1985)       Date:  2012-04-12

2.  Airway responsiveness depends on the diffusion rate of methacholine across the airway wall.

Authors:  Jason H T Bates; Chelsea A Stevenson; Minara Aliyeva; Lennart K A Lundblad
Journal:  J Appl Physiol (1985)       Date:  2012-03-01

3.  Modeling the dynamics of airway constriction: effects of agonist transport and binding.

Authors:  Samir D Amin; Arnab Majumdar; Urs Frey; Béla Suki
Journal:  J Appl Physiol (1985)       Date:  2010-05-27

4.  Role of TNFR1 in lung injury and altered lung function induced by the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide.

Authors:  Vasanthi R Sunil; Kinal Patel-Vayas; Jianliang Shen; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-11-09       Impact factor: 4.219

5.  In silico modeling of interstitial lung mechanics: implications for disease development and repair.

Authors:  Béla Suki; Arnab Majumdar; Matthew A Nugent; Jason H T Bates
Journal:  Drug Discov Today Dis Models       Date:  2007

6.  Revisiting atelectasis in lung units with low ventilation/perfusion ratios.

Authors:  James P Butler; Atul Malhotra; Stephen H Loring
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

7.  Transient oscillatory force-length behavior of activated airway smooth muscle.

Authors:  J H T Bates; S R Bullimore; A Z Politi; J Sneyd; R C Anafi; A-M Lauzon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-12       Impact factor: 5.464

Review 8.  Physiological Mechanisms of Airway Hyperresponsiveness in Obese Asthma.

Authors:  Jason H T Bates
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

9.  Antigen-induced mast cell expansion and bronchoconstriction in a mouse model of asthma.

Authors:  Shannon Li; Minara Aliyeva; Nirav Daphtary; Rebecca A Martin; Matthew E Poynter; Shannon F Kostin; Jos L van der Velden; Alexandra M Hyman; Christopher S Stevenson; Jonathan E Phillips; Lennart K A Lundblad
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

10.  Ozone-induced injury and oxidative stress in bronchiolar epithelium are associated with altered pulmonary mechanics.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Christopher B Massa; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2013-03-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.